Kircik Leon H
Mount Sinai Medical Center, New York, NY, USA.
J Drugs Dermatol. 2013 Feb;12(2):s3-4.
As the accumulated clinical evidence and experience to be presented in the next several pages demonstrate, the unique engineering of the clocortolone pivalate molecule balances potency with documented efficacy and a favorable safety profile. Clocortolone pivalate 0.1% cream is a well-formulated and versatile therapeutic option to consider for many of our patients with steroid-responsive dermatoses.
正如接下来几页将展示的累积临床证据和经验所示,特戊酸氯泼尼醇分子独特的设计使其在效力、已证实的疗效和良好的安全性之间达到了平衡。0.1%特戊酸氯泼尼醇乳膏是一种配方精良且用途广泛的治疗选择,可供我们许多患有类固醇反应性皮肤病的患者考虑。